Clinical studies have shown that there is consistently around a 25–30% increase in plasma BDNF levels in individuals responding to SSRIs/SNRIs treatments, and this increase in plasma BDNF levels is correlated with symptom remission of depression. This evidence concerns the gene BDNF and depressive disorder.